Pegasus Biotech is excited to announce that the company has been selected as a finalist for the 2023 Greater Charlottetown Chamber of Commerce President’s Excellence Awards in the category of Emerging Business Excellence.
“We are honored to be short-listed for this award. Our success and rapid growth are due to the hard work put in by Pegasus’ employees, and the support of the PEI and Canadian biotech ecosystem over the past two years of operation,” said Dr. Yimy Mena, CEO of Pegasus Biotech. Over the past 24 months, Pegasus Biotech has experienced a 10-fold growth in revenue and size, signing contracts with clients in North America, South America, Europe and Asia. This has established the company as a global player in the biotechnology CRO industry and the CRO of choice for DNA vaccine development services.
The mission of Pegasus Biotech is to enable their clients to bring cutting edge innovation to the global human and animal health markets. Their area of expertise is ensuring that client biopharmaceutical and vaccine development activities result in commercially viable products that are compliant with global regulations.
To learn more about Pegasus’ services, click here.
About Pegasus Biotech Inc: Pegasus Biotech Inc. is a full-service biotechnology contract research organization. They offer both process and analytical development services to the global pharma industry. They specialize in vaccine and biopharmaceutical development and are global leaders in DNA vaccine development.